Immunogenicity and Safety of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Tdap Vaccine: Randomized Phase IIIb Trial in Healthy Participants 9-60 Years of Age in the Philippines.

Journal Information

Full Title: Pediatr Infect Dis J

Abbreviation: Pediatr Infect Dis J

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Communicable Diseases

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
2/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"T.C.M., C.V., C.Z., M.-L.T. and S.M. are employees of Sanofi Pasteur and may hold shares and/or stock options in the company. The other authors have no conflicts of interest to disclose."

Evidence found in paper:

"Sanofi Pasteur funded this study and was involved in the study design, the collection, analysis and interpretation of data, the writing of the report, and the decision to submit the article for publication. All authors had full access to all the data in the study and had final responsibility for the decision to submit for publication."

Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025